Marna B. Williams

机构：AstraZeneca (United States)

发表论文 59 篇 · 总被引 3482 次 · h-index 23

代表论文

CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma (2008 · Clinical Cancer Research · 被引 566)
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial (2014 · The Lancet · 被引 458)
Antibody–Drug Conjugates: Future Directions in Clinical and Translational Strategies to Improve the Therapeutic Index (2019 · Clinical Cancer Research · 被引 293)
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis (2012 · Gut · 被引 151)
Anti-CD22-MCC-DM1: an antibody-drug conjugate with a stable linker for the treatment of non-Hodgkin's lymphoma (2010 · Leukemia · 被引 88)
DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody–Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma (2013 · Molecular Cancer Therapeutics · 被引 85)